The Ultimate Guide To Bydureon Pen For Diabetes

image of bydureon pen

Bydureon pen is a glucagon-like peptide-1 belonging to the group of incretin mimetic and was approved in April 2005 for treating Type 2 diabetes mellitus and on January 27, 2012, it was again approved as a once in a week medication.

It’s a prescription medicine that improves the blood glucose though it has not been recommended as the first choice for treating the above-said condition.

How Does A Bydureon Work?

Bydureon is a medicine that works by helping one’s body release its own insulin when there is a need to reduce blood sugar levels.

It contains the active ingredient exenatide that works by mimicking the actions of a hormone called glucagon-like peptide-1 hormone which is produced by the body naturally upon food intake.

Glucagon-like peptide-1 or GLP-1 does four major roles that help in the control of blood glucose.

First, GLP-1 reduces the rate at which food passes from the stomach into the intestines, this slows down glucose absorption from the gut into the bloodstream.

Secondly, GLP-1 reduces glucagon production, a hormone that trigger increased glucose production by the liver.

GLP-1 also acts on the brain causing a feeling of fullness which in turn reduces further the level of food intake.

Finally, it stimulates the pancreas to produce insulin in response to increasing levels of glucose in the blood.

Exenatide mimicks these actions of GLP-1 hence helping control blood sugar levels in persons with type 2 diabetes.

Bydureon injection is made in a unique way to provide a reservoir of exenatide under the skin. From this reservoir, exenatide is slowly released into the bloodstream continuously to give a steady level of the medicine in the blood.

In order for exenatide to work, it has to reach an optimal level know as a steady state which takes about six to seven weeks. After that, the level of exenatide is maintained with continued once in a week injection.

Many patients may experience some side effects such as nausea, diarrhea, constipation, headache, vomiting, a small bump at the injection site and indigestion.

These may not be all the side effects and may differ among patients. It is advisable that you consult your health specialist or doctor about the side effects that you may experience during the course of your medication.

Recent studies also indicate that this medication leads to some significant weight loss but it’s not recommended or approved as a weight loss drug and therefore its misuse must highly be discouraged.

How To Use Bydureon Pen?

Type 2 diabetes is a serious disease as you know affecting everyone from all walks of life from children to the adults and therefore needs proper management with the use of bydureon pen which is a medication that you only take once in a week and eliminates the need for you to transfer the medication between vial and syringe.

Its indicated as an adjunct to exercise and diet to improve glycemic in adults with type 2 diabetes mellitus.

One dose lasts for seven days with each dose providing a gradual increase in the amount of exenatide in your blood as it is released from the tiny particles.

Your diabetes specialist or doctor will guide you on how to administer bydureon correctly before you use it for the first time.

Make sure you fully understand what to do and if you have any questions concerning the medication ensure you ask.

Take note of the following instructions when using bydureon injection:
This injection is administered under the skin of the upper arm, thigh or abdomen on once in a weekly basis.

It should be used on the same day each week, in this case, one may use a calendar to eliminate any chance of forgetfulness.

It can be taken at any time of the day with or without meals.
This medicine may be used with other oral diabetes medicines.

You have the chance to control your blood sugar levels if you consistently take bydureon every week as directed by your doctor along with exercise and diet.

What Is Bydureon Pen Used For?

Bydureon pen is used for people with Type 2 diabetes whose bodies are not able to effectively use or produce insulin properly.

This means that their blood sugar levels are not controlled by either a glitazone, a sulphonylurea or metformin or a combination of metformin with a sulphonylurea or glitazone.

Based on research conducted on animals this medicine may cause fatal harm to the fetus and therefore should not be administered during pregnancy.

It should also not be used in patients with type 1 diabetes or diabetic ketoacidosis or along with insulin.

What Is A Bydureon Pen?

Bydureon is a pen pre-filled, single used pen injector, its a new treatment for type 2 diabetes and works by helping the body release its own insulin when needed to reduce glucose present in the blood.

It is a treatment of its kind as it has a unique continuous release delivery system under the skin. Each dose is made of microspheres (tiny particles) that gradually release the medicine into your body.

Cost Of Bydureon

Bydureon is the brand name of exenatide and its most common version costs around $750 to $800 for one kit which consists of four 2mg injector pens.

In conclusion, recent medical research conducted estimated that more than 380 million people globally are affected by diabetes, with Type 2 diabetes accounting for approximately 89-95 percent of all diagnosed diabetes cases.

Bydureon has played a major role in the management of diabetes but many patients still remain inadequately controlled on their current glucose levels.

More efforts need to be placed by all stakeholders such as World Health Organization and the government agencies across the world to ensure the prevalence of diabetes is achieved which is a project targeted to reach more than 500 million people across the globe by the year 2055.

We all need to be part of this life changing campaign that will see a generation of applicable solutions to the diabetic issue affect the human race worldwide.

With the help of technology, it’s possible to hasten the prevalence project to save the many lives claimed by the diabetic menace.